Royalty Pharma Stock Discussion

$Syndax Pharmaceuticals (SNDX.US)$ $Royalty Pharma (RPRX.US)$ Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)
Dow Jones· 1 min ago

$Royalty Pharma (RPRX.US)$ ur past dur.. lets pop

What did Warren Buffett Buy in Q2?
During the second quarter, Warren Buffett's $Berkshire Hathaway-A (BRK.A.US)$ added 3.9 million shares of $Apple (AAPL.US)$ stock, worth a total of $125.1 billion and tripled its stake in auto and home loan company $Ally Financial (ALLY.US)$ to 30 million shares worth $1 billion, according to the recently released 13F filing.
Besides, the "Sage of Omaha" also doubled down on its energy investments by further buying ...

Upgrades
• $B&G Foods (BGS.US)$ : Piper Sandler Upgrades to Neutral from Underweight - PT $23 (from $25)
• $Nokia Oyj (NOK.US)$ : Citigroup Upgrades to Buy from Neutral
• $NetApp (NTAP.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $84 (from $90)
• $PBF Energy (PBF.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $57 (from $30)
• $US Silica (SLCA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $20
• $Thomson Reuters (TRI.US)$ : CIBC Up...

$Berkshire Hathaway-A (BRK.A.US)$
$Berkshire Hathaway-B (BRK.B.US)$
Warren Buffett's Berkshire Hathaway disclosed in an SEC filing its holdings as of March 31, 2022. The fund's eight new buys during the first quarter included, by size of position, $Occidental Petroleum (OXY.US)$, HP Inc. $HP Inc (HPQ.US)$ , $Citigroup (C.US)$ , $Paramount Global-B (PARA.US)$ , and $Celanese Corp (CE.US)$. 
Berkshire exited three positions during the quarter, including by size of previous position $AbbVie (ABBV.US)$ ,...

Upgrades
• $Ares Capital Corp (ARCC.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $22
• $Avery Dennison (AVY.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $195
• $Avery Dennison (AVY.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $195 (from $215)
• $Brookfield Asset Management (BAM.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $71.50 (from $68)
• $Ecolab (ECL.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $1...